Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities (Q39053500)
Jump to navigation
Jump to search
scientific article published on June 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities |
scientific article published on June 2014 |
Statements
1 reference
Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities (English)
1 reference
Anne-Christine Piguet
Syamantak Majumder
Uma Maheshwari
Reji Manjunathan
Uttara Saran
1 June 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference